Cardiovascular injuries and SARS-COV-2 infection:focus on elderly people

作     者：Claudia Colombo Laura Garatti Giulia Ferrante Francesca Casadei Claudio Montalto Gabriele Crimi Chiara Cogliati Enrico Ammirati Stefano Savonitto Nuccia Morici Claudia Colombo;Laura Garatti;Giulia Ferrante;Francesca Casadei;Claudio Montalto;Gabriele Crimi;Chiara Cogliati;Enrico Ammirati;Stefano Savonitto;Nuccia Morici

作者机构：Department of Cardiology De Gasperis Cardio CenterASST Grande Ospedale Metropolitano NiguardaMilanItaly School of Medicine and SurgeryUniversity of Milano BicoccaItaly Division of CardiologyHeart and Lung DepartmentSan Paolo HospitalASST Santi Paolo and CarloUniversity of MilanItaly Division of CardiologyUniversity of PaviaPaviaLombardiaItaly Interventional Cardiology UnitCardio Thoraco Vascular Department(DICATOV)IR-CCS Policlinico San MartinoGenovaItaly Internal MedicineDepartment of Medicine and RiabilitationASST Fatebenefratelli-SaccoLuigi Sacco HospitalMilanItaly De Gasperis Cardio Center and Transplant CenterNiguarda HospitalMilanItaly Division of CardiologyOspedale ManzoniLeccoItaly 

出 版 物：《Journal of Geriatric Cardiology》 (老年心脏病学杂志（英文版）)

年 卷 期：2021年第18卷第7期

页      面：534-548页

核心收录：

学科分类：1002[医学-临床医学] 10[医学] 

主　　题：injuries cardiovascular infection 

摘      要：The novel coronavirus disease(COVID-19)has hit the healthcare system worldwide.The risk of severe infection and mortality increases with advancing age,especially in subjects with comorbidities such as cardiovascular disease,hypertension,diabetes,obesity and cancer.Moreover,cardiovascular complications such as myocardial injury,heart failure and thromboembolism are frequently observed in COVID-19 cases,and several biomarkers(troponin,NTpro BNP and D-Dimer)have been identified as prognostic indicators of disease severity and worst outcome.Currently,there is no specific therapy against SARS-Co V-2,although many medications are under investigation.The aim of this review will be to explore the intertwined relationship between COVID-19 disease and the cardiovascular system,focusing on elderly population.The available supportive treatments along with the related concerns in elderly patients,due to their comorbidities and polypharmacotherapy,will be explored.